ROYAL BANK OF CANADA - TALIS BIOMEDICAL CORP ownership

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$0150
+22.0%
0.00%
Q1 2023$01230.0%0.00%
Q4 2022$0123
-61.6%
0.00%
Q3 2022$03200.0%0.00%
Q2 2022$0
-100.0%
320
-72.4%
0.00%
Q1 2022$1,000
-90.9%
1,158
-60.6%
0.00%
Q4 2021$11,000
-8.3%
2,938
+55.7%
0.00%
Q3 2021$12,000
-7.7%
1,887
+61.1%
0.00%
Q2 2021$13,000
-18.8%
1,171
-8.1%
0.00%
Q1 2021$16,0001,2740.00%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,073,1760.05%
WELLS FARGO & COMPANY/MN 174$840.00%
NORTHERN TRUST CORP 27,860$13,3730.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 140,530$67,4540.00%
STATE STREET CORP 47,436$22,7690.00%
MILLENNIUM MANAGEMENT LLC 91,463$43,9020.00%
DEUTSCHE BANK AG\ 45,294$21,7410.00%
MORGAN STANLEY 61,857$29,6910.00%
BlackRock Inc. 76,307$36,6280.00%
View complete list of TALIS BIOMEDICAL CORP shareholders